INNOVATION PHARMACEUTICALS INC. Convertible Debt
INNOVATION PHARMACEUTICALS INC. had Convertible Debt of $1.08 thousand as of 2023-09-30, per its 10-Q filed 2023-11-20.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:ConvertibleDebt · last filed 2023-11-20
- 2023-09-30: Convertible Debt $1.08K.
- 2023-06-30: Convertible Debt $1.08K.
- 2023-03-31: Convertible Debt $1.08K.
- 2022-12-31: Convertible Debt $1.08K.
| Period end | Convertible Debt |
|---|---|
| 2023-09-30 | $1.08K 10-Q · filed 2023-11-20 |
| 2023-06-30 | $1.08K 10-Q · filed 2023-11-20 |
| 2023-03-31 | $1.08K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $1.08K 10-Q · filed 2023-02-15 |
| 2022-06-30 | $1.08K 10-K · filed 2023-09-28 |